Loading
Total declarations
Company
▲ Purchases (3 ops.)
▼ Sales (0 ops.)
Latest filing published 14 Oct 2021 for Agile Therapeutics INC. Read the official filing
Filing timeline
BuySaleDennis Reilly
Insider track record
Disclosed buys
3
Disclosed sells
0
Not enough buy signals with a settled T+90 horizon to measure a track record yet.
Signal history
Dennis Reilly: trading record in brief
All filings by Dennis Reilly on record concern Agile Therapeutics Inc, in the capacity of finance chief. Over a trading history stretching from 11 May 2021 to 13 October 2021, the count stands at 3 filings.
On the market, this insider has only ever bought: 3 purchases, €68k in total. The amount is not disclosed for 1 filing. Unlike grants, an open-market purchase is paid for by the insider, at the market price.
Across 3 purchases, this insider has always bought alone, with no colleague buying within 30 days.
Most recently, on 14 October 2021, the filings show an open-market purchase in Agile Therapeutics Inc. The median gap between a trade and its publication by SEC (Form 4) is 1 day. The legal deadline for a Form 4 is two business days after the transaction. This summary is built from SEC (Form 4) disclosures alone and does not predict where the share price will go.
Companies and markets linked to Dennis Reilly
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
Declarations3 total
58,824 sharesCommon StockSEC:0001104659-21-126014:0
Canonical exit: 11 Jan 2022 (T+90)
50,000 shares@ US$1.082967.3% of flowCommon StockSEC:0001104659-21-097152:0
Canonical exit: 25 Oct 2021 (T+90)
20,000 shares@ US$1.3532.7% of flowCommon StockSEC:0001104659-21-065161:0
Canonical exit: 9 Aug 2021 (T+90)
3 of 3 declarations
